Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers S > Headlines for Somaxon Pharmaceuticals, Inc. > News item |
Somaxon files $75 million shelf registration
By Laura Lutz
Washington, Dec. 20 - Somaxon Pharmaceuticals, Inc. filed a $75 million shelf registration in an S-3 filing with the Securities and Exchange Commission.
The registration covers debt securities, preferred stock, common stock, debt warrants and equity warrants. Securities may be structured as convertibles.
Proceeds will be used to fund clinical and preclinical development of product candidates and for general corporate purposes.
Based in San Diego, Somaxon is a specialty pharmaceutical company focused on psychiatry and neurology.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.